Bicycle Therapeutics
BCYC
110 hedge funds and large institutions have $286M invested in Bicycle Therapeutics in 2025 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 37 increasing their positions, 21 reducing their positions, and 14 closing their positions.
223% more call options, than puts
Call options by funds: $407K | Put options by funds: $126K
107% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 14
76% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 21
16% more funds holding
Funds holding: 95 → 110 (+15)
0.82% less ownership
Funds ownership: 60.31% → 59.49% (-0.82%)
19% less capital invested
Capital invested by funds: $354M → $286M (-$68M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$7.89M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$4.56M |
| 3 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$3.47M |
| 4 |
TCM
Tybourne Capital Management
Hong Kong
|
+$3.32M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$15.3M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$9.28M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
-$7.73M |
| 4 |
Axa
Paris,
France
|
-$2.18M |
| 5 |
BNP Paribas Asset Management
Paris,
France
|
-$1.42M |
BCYC Hedge Fund Activity: Q2 2025 in Review
110 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q2 2025, worth a combined $286M — down 19% from $354M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new BCYC positions and 14 closed out — a net gain of 15 holders — while 37 added to existing stakes and 21 trimmed.
The largest buyer was Millennium Management, adding an estimated $7.89M. The largest seller was Point72 Asset Management, cutting an estimated $15.3M.
- 110 institutional investors held Bicycle Therapeutics (BCYC) as of Q2 2025, up from 95 in Q1 2025.
- Funds reported $286M of Bicycle Therapeutics stock for Q2 2025, down 19% quarter-over-quarter.
- 29 funds opened new Bicycle Therapeutics positions in Q2 2025 and 14 closed out, a net change of +15 holders.
- The largest Bicycle Therapeutics buyer in Q2 2025 was Millennium Management, an estimated $7.89M added.
- The largest Bicycle Therapeutics seller in Q2 2025 was Point72 Asset Management, an estimated $15.3M sold.
Based on aggregated 13F filings for Q2 2025.